Claudio Maria Mastroianni

Pubblicazioni

Titolo Pubblicato in Anno
Modulation of phenylalanine and tyrosine metabolism in HIV-1 infected patients with neurocognitive impairment: results from a clinical trial METABOLITES 2020
Major reduction of NKT cells in patients with severe COVID-19 pneumonia CLINICAL IMMUNOLOGY 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization LE INFEZIONI IN MEDICINA 2020
Efficacy of daptomycin-containing regimen for treatment of staphylococcal or enterococcal vertebral osteomyelitis: A prospective clinical experience ANTIBIOTICS 2020
Unexpected increase of myocardial extracellular volume fraction in low cardiovascular risk HIV patients TRANSLATIONAL MEDICINE COMMUNICATIONS 2020
Anosmia and ageusia as predictive signs of COVID-19 in healthcare workers in Italy: a prospective case-control study JOURNAL OF CLINICAL MEDICINE 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) OPEN FORUM INFECTIOUS DISEASES 2020
False-negative RT-PCR in SARS-CoV-2 disease: experience from an Italian COVID-19 unit ERJ OPEN RESEARCH 2020
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) CARDIOVASCULAR DIABETOLOGY 2020
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2020
qSOFA as a new community-acquired pneumonia severity score in the emergency setting EMERGENCY MEDICINE JOURNAL 2020
Is teicoplanin a complementary treatment option for COVID-19? The question remains INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2020
Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial JOURNAL OF MEDICAL VIROLOGY 2020
Clinical features of patients with type 2 diabetes with and without Covid-19: A case control study (CoViDiab I) DIABETES RESEARCH AND CLINICAL PRACTICE 2020
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19 BRITISH JOURNAL OF HAEMATOLOGY 2020
Nox2 activation in Covid-19 REDOX BIOLOGY 2020
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19 FRONTIERS IN MEDICINE 2020
Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis EUROPEAN RADIOLOGY 2020
Is Albumin Predictor of Mortality in COVID-19? ANTIOXIDANTS & REDOX SIGNALING 2020

ERC

  • LS6
  • LS6_6
  • LS6_8
  • LS6_9
  • LS6_11

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

Infezione da HIV, Tubercolosi, Infezioni del SNC, COVID-19, Terapie innovative delle malattie infettive, antimicrobico resistenza, Studio delle interazioni tra sistema immunitario e infezioni, Infezioni correlate all'assistenza sanitaria, Patogenesi delle infezioni virali

Keywords

antiretroviral therapy hiv
antimicrobial combinations
2019 novel coronavirus
tuberculosis
Bacterial Infections
innate immunity
antimicrobial resistance

Progetti di Ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma